Skip to main content
OpenTrials
Completed

NCT Number: NCT02622854

Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis

To compare effectiveness in reducing triglycerides between daily plasma exchange and glucose+insulin infusion in patients with non-severe acute hypertriglyceridemic pancreatitis with mildly elevated triglycerides

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Medical Centre Ljubljana, Ljubljana, Slovenia

Ljubljana, 1000, Slovenia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • mild acute hypertriglyceridemic pancreatitis
  • triglycerides >15 but < 40 mmol/l

Exclusion criteria

  • pregnancy
  • severe course of pancreatitis

Treatment and study plan

Plasma Exchange

Procedure

see arm description

Conservative treatment

Drug

see arm description

Other names: glucose and insulin

Primary outcomes

  1. decrease in triglycerides

    Time frame: within first 24 h after admission

    as % of starting value

Secondary outcomes

  1. time until triglycerides drop to <10 mmol/l

    Time frame: by the end of hospital stay, up to 100 days

    expressed in days

  2. highest C-reactive protein (CRP)

    Time frame: by the end of hospital stay, up to 100 days

  3. % of patients with severe pancreatitis

    Time frame: by the end of hospital stay, up to 100 days

Sponsors and collaborators

Lead sponsor

University Medical Centre Ljubljana

Other

Registry information

Official study title

Comparison of Plasma Exchange and Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis With Mildly Elevated Triglycerides

Important dates

Study start
2016
Primary completion
2020
Study completion
2020
First posted
Dec 7, 2015
Registry last updated
Nov 30, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.